Computational tool developed to predict immunotherapy outcomes for patients with metastatic breast cancer

Using computational tools, researchers have developed a method to assess which patients with metastatic triple-negative breast cancer could benefit from immunotherapy.

from Breast Cancer News -- ScienceDaily https://ift.tt/lKjS3iN